Format

Send to:

Choose Destination
See comment in PubMed Commons below
Jpn J Clin Oncol. 2013 Apr;43(4):357-61. doi: 10.1093/jjco/hyt023. Epub 2013 Mar 14.

Takeda's Oncology Discovery Strategy.

Author information

  • 1Millennium Pharmaceuticals, Inc., Cambridge, MA, USA.

Abstract

Takeda's Oncology Discovery Strategy is tightly integrated and focused on first and fast-best-in-class products and product combinations. Core areas of expertise include hormones, protein homeostasis, biotherapeutics and signal transduction. Strategic imperatives for research success are understanding of unmet needs, focus on biological expertise in foundational areas of leadership and flexibility to adapt to new information.

PMID:
23493743
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk